http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1084840-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f2ed19fccd5a1a9ea5e6d7846459e43 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565 |
| filingDate | 1979-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1980-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b6176d0e8dc85f8a55eb870dc9be9cd |
| publicationDate | 1980-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1084840-A |
| titleOfInvention | Steroidal erythropoietic agents and therapeutic compositions and methods |
| abstract | ABSTRACT OF THE DISCLOSURE The invention relates to pharmaceutical compositions containing 3.beta.-hydroxy-5.beta.-oestran-17-one. On administration to humans and other warm-blooded animals these compositions simulate erythropoiesis. These composi-tions are particularly advantageous in that they exhibit an unexpected low level of pyrogenicity as compared to etiocholanolone, a known pyrogen. |
| priorityDate | 1976-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.